{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T20:30:29Z","timestamp":1774470629401,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","ghpjournal.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.genhosppsych.2016.07.003","type":"journal-article","created":{"date-parts":[[2016,7,15]],"date-time":"2016-07-15T19:19:30Z","timestamp":1468610370000},"page":"27-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Associations between immune activation and the current severity of the \u201cwith anxious distress\u201d specifier in patients with depressive disorders"],"prefix":"10.1016","volume":"42","author":[{"given":"In Hee","family":"Shim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Sup","family":"Woo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won-Myong","family":"Bahk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.genhosppsych.2016.07.003_bb0005","series-title":"Diagnostic and statistical manual of mental disorders: DSM-5","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.genhosppsych.2016.07.003_bb0010","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/da.22217","article-title":"Major depressive disorder in DSM-5: implications for clinical practice and research of changes from DSM-IV","volume":"31","author":"Uher","year":"2014","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.genhosppsych.2016.07.003_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/YCO.0b013e328340b594","article-title":"DSM-5 proposals for mood disorders: a cost\u2013benefit analysis","volume":"24","author":"First","year":"2011","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2016.07.003_bb0020","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1176\/ajp.153.10.1293","article-title":"Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders","volume":"153","author":"Brown","year":"1996","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2016.07.003_bb0025","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1176\/ajp.149.1.100","article-title":"Anxiety syndromes as epiphenomena of primary major depression: outcome and familial psychopathology","volume":"149","author":"Coryell","year":"1992","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2016.07.003_bb0030","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1600-0447.1989.tb03031.x","article-title":"Outcome of panic and depression in a seven-year follow-up: results of the Zurich study","volume":"80","author":"Vollrath","year":"1989","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.genhosppsych.2016.07.003_bb0035","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1038\/tp.2012.8","article-title":"Association of depressive disorders, depression characteristics and antidepressant medication with inflammation","volume":"2","author":"Vogelzangs","year":"2012","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.genhosppsych.2016.07.003_bb0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbi.2012.04.009","article-title":"The role of immune genes in the association between depression and inflammation: a review of recent clinical studies","volume":"31","author":"Bufalino","year":"2013","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.genhosppsych.2016.07.003_bb0045","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1038\/tp.2013.27","article-title":"Anxiety disorders and inflammation in a large adult cohort","volume":"3","author":"Vogelzangs","year":"2013","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.genhosppsych.2016.07.003_bb0050","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1189\/jlb.0212100","article-title":"The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes","volume":"92","author":"Beumer","year":"2012","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.genhosppsych.2016.07.003_bb0055","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/01.psy.0000174172.82428.ce","article-title":"Clinical depression and regulation of the inflammatory response during acute stress","volume":"67","author":"Miller","year":"2005","journal-title":"Psychosom Med"},{"key":"10.1016\/j.genhosppsych.2016.07.003_bb0060","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.psychres.2011.12.007","article-title":"Serum concentrations of CRP, IL-6, TNF-alpha and cortisol in major depressive disorder with melancholic or atypical features","volume":"198","author":"Karlovi\u0107","year":"2012","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.genhosppsych.2016.07.003_bb0065","doi-asserted-by":"crossref","DOI":"10.1080\/13811118.2015.1004485","article-title":"Alexithymia, suicide ideation, C-reactive protein and serum lipid levels among outpatients with generalized anxiety disorder","author":"De Berardis","year":"2015","journal-title":"Arch Suicide Res"},{"key":"10.1016\/j.genhosppsych.2016.07.003_bb0070","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom Med"},{"key":"10.1016\/j.genhosppsych.2016.07.003_bb0075","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1176\/ajp.147.9.1189","article-title":"Time-related predictors of suicide in major affective disorder","volume":"147","author":"Fawcett","year":"1990","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2016.07.003_bb0080","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jad.2015.08.006","article-title":"Anxiety symptoms are linked to new-onset suicidal ideation after six months of follow-up in outpatients with major depressive disorder","volume":"187","author":"Baek","year":"2015","journal-title":"J Affect Disord"},{"key":"10.1016\/j.genhosppsych.2016.07.003_bb0085","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1017\/S0033291706009147","article-title":"Anxiety disorders and suicidal behaviours in adolescence and young adulthood: findings from a longitudinal study","volume":"37","author":"Boden","year":"2007","journal-title":"Psychol Med"},{"key":"10.1016\/j.genhosppsych.2016.07.003_bb0090","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1017\/S0033291704002612","article-title":"Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D","volume":"34","author":"Fava","year":"2004","journal-title":"Psychol Med"},{"key":"10.1016\/j.genhosppsych.2016.07.003_bb0095","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1176\/appi.ajp.2007.06111868","article-title":"Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report","volume":"165","author":"Fava","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2016.07.003_bb0100","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.pnpbp.2009.03.020","article-title":"Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression","volume":"33","author":"Yoshimura","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.genhosppsych.2016.07.003_bb0105","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1192\/bjp.bp.105.011015","article-title":"Antidepressant therapy and C-reactive protein levels","volume":"188","author":"O'Brien","year":"2006","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2016.07.003_bb0110","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/15622970510029858","article-title":"Agitated depression in bipolar II disorder","volume":"6","author":"Benazzi","year":"2005","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.genhosppsych.2016.07.003_bb0115","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archgenpsychiatry.2009.175","article-title":"National trends in psychotropic medication polypharmacy in office-based psychiatry","volume":"67","author":"Mojtabai","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.genhosppsych.2016.07.003_bb0120","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.pnpbp.2007.12.031","article-title":"Antipsychotic prescriptions in a university hospital outpatient population in Turkey: a retrospective database analysis, 2005-2006","volume":"32","author":"Atik","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.genhosppsych.2016.07.003_bb0125","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1517\/14656560802504490","article-title":"Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial","volume":"9","author":"Mazza","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.genhosppsych.2016.07.003_bb0130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.9758\/cpn.2015.13.1.25","article-title":"Pharmacotherapy of bipolar disorder with quetiapine: a recent literature review and an update","volume":"13","author":"Muneer","year":"2015","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"10.1016\/j.genhosppsych.2016.07.003_bb0135","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s12325-015-0207-3","article-title":"Real-world determinants of adjunctive antipsychotic prescribing for patients with major depressive disorder and inadequate response to antidepressants: a case review study","volume":"32","author":"McIntyre","year":"2015","journal-title":"Adv Ther"},{"key":"10.1016\/j.genhosppsych.2016.07.003_bb0140","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/da.21970","article-title":"Extended release quetiapine fumarate in major depressive disorder: analysis in patients with anxious depression","volume":"29","author":"Thase","year":"2012","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.genhosppsych.2016.07.003_bb0145","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.4088\/JCP.v69n1211","article-title":"Adjunctive aripipraole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features","volume":"69","author":"Trivedi","year":"2008","journal-title":"J Clin Psychiatry"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834316301074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834316301074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T10:26:05Z","timestamp":1536575165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834316301074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":29,"alternative-id":["S0163834316301074"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2016.07.003","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations between immune activation and the current severity of the \u201cwith anxious distress\u201d specifier in patients with depressive disorders","name":"articletitle","label":"Article Title"},{"value":"General Hospital Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2016.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}